Sanofi: Leukemia, Myeloid, Acute trials
The registry lists 16 Leukemia, Myeloid, Acute studies with Sanofi as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 1 8Phase 2 9Phase 3 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological MalignanciesTerminatedNCT06508489Phase 1/2Results posted
- Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaTerminatedNCT03860844Phase 2Results posted
- A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not SuitableCompletedNCT00924443Phase 2Results posted
- A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)CompletedNCT00373529Phase 2Results posted
- A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)CompletedNCT00317642Phase 3Results posted
- A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.CompletedNCT00315705Phase 1/2Results posted
- A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT05712278Phase 1
- Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous LeukemiaWithdrawnNCT02520102Phase 2
- A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)CompletedNCT01090167Phase 1
- Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00990054Phase 1
- Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic SyndromesCompletedNCT00981240Phase 1
- AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDSWithdrawnNCT00396968Phase 1/2
- Clofarabine in Adult Patients With Advanced Solid TumorsCompletedNCT00125840Phase 1
- Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell TransplantCompletedNCT00088543Not applicable
- Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous LeukemiaCompletedNCT00044889Phase 2
- Aminopterin in Treating Patients With Refractory LeukemiaCompletedNCT00003305Phase 2